BRIEF published on 04/10/2026 at 17:50, 1 month 13 days ago Eurobio Scientific Reports prévoit une augmentation de 9 % de son chiffre d'affaires en 2025 Expansion Internationale Marge Brute Bénéfice Net Produits Exclusifs Revenus Annuels
BRIEF published on 04/10/2026 at 17:50, 1 month 13 days ago Eurobio Scientific Reports 9% Revenue Increase for 2025 Gross Margin International Expansion Net Profit Annual Revenue Proprietary Products
PRESS RELEASE published on 04/10/2026 at 17:45, 1 month 13 days ago EUROBIO SCIENTIFIC : 2025 ANNUAL RESULTS Eurobio Scientific reports 9% revenue growth in 2025, with 20% increase in proprietary product sales and 42% international revenue. Strategic plan execution reflected in annual results Revenue Growth Strategic Plan Internationalisation Eurobio Scientific Proprietary Products
BRIEF published on 05/19/2025 at 19:21, 1 year ago EB Development dépasse les 90 % du capital d'Eurobio Scientific Diagnostic In Vitro Réunion Financière Eurobio Scientific Développement EB 90 % Des Actions
BRIEF published on 05/19/2025 at 19:21, 1 year ago EB Development Surpasses 90% Stake in Eurobio Scientific In Vitro Diagnostics Eurobio Scientific EB Development Financial Meeting 90% Shareholding
PRESS RELEASE published on 05/19/2025 at 19:16, 1 year ago Eurobio Scientific: EB Development rises above 90% threshold Eurobio Scientific's shareholder EB Development surpasses 90% share capital threshold through market acquisitions. Financial meeting: Annual General Meeting on June 19, 2025 Share Capital Eurobio Scientific EB Development Financial Meeting 90% Threshold
PRESS RELEASE published on 05/19/2025 at 19:16, 1 year ago Eurobio Scientific : EB Development franchit à la hausse le seuil de 90% EB Development franchit à la hausse le seuil de 90% du capital d'Eurobio Scientific suite à une acquisition d'actions sur le marché. Prochain rendez-vous financier : Assemblée générale le 19 juin 2025 Franchissement De Seuil Assemblée Générale Diagnostic Médical Eurobio Scientific EB Development
BRIEF published on 04/29/2025 at 21:05, 1 year ago Mise à disposition du rapport financier annuel 2024 par Eurobio Scientific Diagnostic In Vitro Assemblée Générale Investisseurs Rapport Annuel 2024 Eurobio Scientific
BRIEF published on 04/29/2025 at 21:05, 1 year ago Availability of the 2024 annual financial report by Eurobio Scientific Investors In Vitro Diagnostics General Meeting Annual Report 2024 Eurobio Scientific
PRESS RELEASE published on 04/29/2025 at 21:00, 1 year ago Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024 Eurobio Scientific annonce la mise à disposition de son rapport financier annuel 2024 auprès du public et de l'AMF Assemblée Générale Investisseurs Rapport Financier Annuel Diagnostic Médical Eurobio Scientific
Published on 05/23/2026 at 19:45, 11 hours 18 minutes ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 1 day 3 hours ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 day 4 hours ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 day 4 hours ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 day 4 hours ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/24/2026 at 05:55, 1 hour 8 minutes ago The 26th CIFIT to Open in Xiamen This September, Preceded by Successful Guangzhou Roadshow
Published on 05/24/2026 at 05:35, 1 hour 28 minutes ago CGTN: Xizang at 75: Development and culture create a 'miracle on Earth'
Published on 05/23/2026 at 16:30, 14 hours 33 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 15 hours 6 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 8 hours ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 19:35, 1 day 11 hours ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 12 hours ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 12 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 18 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 18 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
